Insider · CIK 0001650476
Fletcher Payne
Files at APTO (Aptose Biosciences Inc.). First filing -, latest -.
In brief
Fletcher Payne files SEC Form 4 as CFO at APTO (Aptose Biosciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Fletcher Payne has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | APTO Aptose Biosciences Inc. | DDisposition to issuer Common Shares | -222 | $1.72 | $382 | 0 | Jul 1, 2026 |
| Jun 30, 2026 | APTO Aptose Biosciences Inc. | DDisposition to issuer Common Sharesindirect: Fletcher Payne 2019 Trust | -22 | $1.72 | $38 | 0 | Jul 1, 2026 |
| Jun 30, 2026 | APTO Aptose Biosciences Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 0 | Jul 1, 2026 |
| Jun 30, 2026 | APTO Aptose Biosciences Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -200,000 | $0.00 | $0 | 0 | Jul 1, 2026 |
| Jun 30, 2026 | APTO Aptose Biosciences Inc. | DDisposition to issuer Common Stock (Option)derivative | -1,000,000 | $0.00 | $0 | 0 | Jul 1, 2026 |
| Feb 5, 2024 | APTO Aptose Biosciences Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Feb 7, 2024 |
Questions about Fletcher Payne
Answered from the filings on this page, as of the latest one.
Is Fletcher Payne buying or selling?
Fletcher Payne has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Fletcher Payne's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Fletcher Payne has 0.
Where does Fletcher Payne file Form 4?
Fletcher Payne has filed Form 4 at APTO (Aptose Biosciences Inc.) as Sr VP and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.